Business · 10/11/1997Updated: 10/17/2026 · 1 min read
FDA Requests Comments on Proposed Revisions to Expedited Review List for Human Subjects Research
Summary
The FDA is seeking public input on potential updates to its Expedited Review List, which identifies research involving human subjects that can be reviewed through expedited procedures, following significant advances in medicine and technology.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →